SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001701541-22-000029
Filing Date
2022-08-09
Accepted
2022-08-09 07:31:04
Documents
58
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bdtx-20220630.htm   iXBRL 10-Q 1073003
2 EX-10.1 blackdiamond-executiveempl.htm EX-10.1 87277
3 EX-31.1 exhibit311_q22022.htm EX-31.1 12498
4 EX-31.2 exhibit312_q22022.htm EX-31.2 12332
5 EX-32.1 exhibit321_q22022.htm EX-32.1 9407
  Complete submission text file 0001701541-22-000029.txt   4955787

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bdtx-20220630.xsd EX-101.SCH 27289
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bdtx-20220630_cal.xml EX-101.CAL 51418
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bdtx-20220630_def.xml EX-101.DEF 106445
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bdtx-20220630_lab.xml EX-101.LAB 421161
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bdtx-20220630_pre.xml EX-101.PRE 261675
52 EXTRACTED XBRL INSTANCE DOCUMENT bdtx-20220630_htm.xml XML 823184
Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Filer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39200 | Film No.: 221146411
SIC: 2836 Biological Products, (No Diagnostic Substances)